Relationship between hepatocellular carcinoma, metabolic syndrome and non-alcoholic fatty liver disease: Which clinical arguments?

Annales d'Endocrinologie

Volumn 74, Issue 2, 2013, Pages 115-120

  Rosmorduc, Olivier ^a  

^a CENTRE DE RECHERCHE SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALCOHOL; LEPTIN;

ALCOHOL ABUSE; ARTICLE; CANCER INCIDENCE; CANCER RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; HORMONE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER RESECTION; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; RISK FACTOR; VIRUS HEPATITIS;

EID: 84877604460     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2013.02.008     Document Type: Article

References (50)

1. El-Serag H.B., Lau M., Eschbach K., Davila J., Goodwin J. Epidemiology of hepatocellular carcinoma in Hispanics in the United States. Arch Intern Med 2007, 167:1983-1989.
2. Bedogni G., Miglioli L., Masutti F., Tiribelli C., Marchesini G., Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005, 42:44-52.
3. Matteoni C.A., Younossi Z.M., Gramlich T., Boparai N., Liu Y.C., McCullough A.J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999, 116:1413-1419.
4. Adams L.A., Lymp J.F., St Sauver J., Sanderson S.O., Lindor K.D., Feldstein A., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
5. Hui J.M., Kench J.G., Chitturi S., Sud A., Farrell G.C., Byth K., et al. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 2003, 38:420-427.
6. Poonawala A., Nair S.P., Thuluvath P.J. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000, 32:689-692.
7. Ratziu V., Bonyhay L., Di Martino V., Charlotte F., Cavallaro L., Sayegh-Tainturier M.H., et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002, 35:1485-1493.
8. Ekstedt M., Franzen L.E., Mathiesen U.L., Thorelius L., Holmqvist M., Bodemar G., et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006, 44:865-873.
9. Rafiq N., Bai C., Fang Y., Srishord M., McCullough A., Gramlich T., et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 2009, 7:234-238.
10. de Lima V.M., Oliveira C.P., Alves V.A., Chammas M.C., Oliveira E.P., Stefano J.T., et al. A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma. J Hepatol 2008, 49:1055-1061.
11. Caldwell S.H., Oelsner D.H., Iezzoni J.C., Hespenheide E.E., Battle E.H., Driscoll C.J. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999, 29:664-669.
12. Bugianesi E. Non-alcoholic steatohepatitis and cancer. Clin Liver Dis 2007, 11:191-207. [x-xi].
13. Powell E.E., Cooksley W.G., Hanson R., Searle J., Halliday J.W., Powell L.W. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21years. Hepatology 1990, 11:74-80.
14. Bugianesi E., Leone N., Vanni E., Marchesini G., Brunello F., Carucci P., et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002, 123:134-140.
15. Marrero J.A., Fontana R.J., Su G.L., Conjeevaram H.S., Emick D.M., Lok A.S. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002, 36:1349-1354.
16. Bullock R.E., Zaitoun A.M., Aithal G.P., Ryder S.D., Beckingham I.J., Lobo D.N. Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma. J Hepatol 2004, 41:685-686.
17. Zen Y., Katayanagi K., Tsuneyama K., Harada K., Araki I., Nakanuma Y. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol Int 2001, 51:127-131.
18. Hashimoto E., Yatsuji S., Tobari M., Taniai M., Torii N., Tokushige K., et al. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol 2009, 44(Suppl. 19):89-95.
19. Paradis V., Zalinski S., Chelbi E., Guedj N., Degos F., Vilgrain V., et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology 2009, 49:851-859.
20. Ertle J., Dechene A., Sowa J.P., Penndorf V., Herzer K., Kaiser G., et al. Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int J Cancer 2011, 128:2436-2443.
21. Chitturi S., Farrell G., Frost L., Kriketos A., Lin R., Fung C., et al. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?. Hepatology 2002, 36:403-409.
22. Wang S.N., Lee K.T., Ker C.G. Leptin in hepatocellular carcinoma. World J Gastroenterol 2010, 16:5801-5809.
23. Ikejima K., Takei Y., Honda H., Hirose M., Yoshikawa M., Zhang Y.J., et al. Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology 2002, 122:1399-1410.
24. Nkontchou G., Bastard J.P., Ziol M., Aout M., Cosson E., Ganne-Carrie N., et al. Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis. J Hepatol 2010, 53:827-833.
25. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003, 348:1625-1638.
26. Larsson S.C., Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer 2007, 97:1005-1008.
27. Wolk A., Gridley G., Svensson M., Nyren O., McLaughlin J.K., Fraumeni J.F., et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 2001, 12:13-21.
28. Polesel J., Zucchetto A., Montella M., Dal Maso L., Crispo A., La Vecchia C., et al. The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol 2009, 20:353-357.
29. Moller H., Mellemgaard A., Lindvig K., Olsen J.H. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994, 30A:344-350.
30. Oh S.W., Yoon Y.S., Shin S.A. Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol 2005, 23:4742-4754.
31. Park S.M., Lim M.K., Shin S.A., Yun Y.H. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol 2006, 24:5017-5024.
32. Nair S., Mason A., Eason J., Loss G., Perrillo R.P. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?. Hepatology 2002, 36:150-155.
33. Ohki T., Tateishi R., Shiina S., Goto E., Sato T., Nakagawa H., et al. Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH. Gut 2009, 58:839-844.
34. Lagiou P., Kuper H., Stuver S.O., Tzonou A., Trichopoulos D., Adami H.O. Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst 2000, 92:1096-1099.
35. El-Serag H.B., Tran T., Everhart J.E. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004, 126:460-468.
36. Jee S.H., Ohrr H., Sull J.W., Yun J.E., Ji M., Samet J.M. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005, 293:194-202.
37. Donadon V., Balbi M., Mas M.D., Casarin P., Zanette G. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease. Liver Int 2010, 30:750-758.
38. El-Serag H.B., Johnson M.L., Hachem C., Morgana R.O. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology 2009, 136:1601-1608.
39. El-Serag H.B., Hampel H., Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006, 4:369-380.
40. Chen H.F., Chen P., Li C.Y. Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications. Hepatology 2010, 52:155-163.
41. Hassan M.M., Hwang L.Y., Hatten C.J., Swaim M., Li D., Abbruzzese J.L., et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002, 36:1206-1213.
42. Ohata K., Hamasaki K., Toriyama K., Matsumoto K., Saeki A., Yanagi K., et al. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 2003, 97:3036-3043.
43. Pekow J.R., Bhan A.K., Zheng H., Chung R.T. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer 2007, 109:2490-2496.
44. Chen C.L., Yang H.I., Yang W.S., Liu C.J., Chen P.J., You S.L., et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008, 135:111-121.
45. Konishi I., Hiasa Y., Shigematsu S., Hirooka M., Furukawa S., Abe M., et al. Diabetes pattern on the 75g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus. Liver Int 2009, 29:1194-1201.
46. Yu M.W., Shih W.L., Lin C.L., Liu C.J., Jian J.W., Tsai K.S., et al. Body-mass index and progression of hepatitis B: a population-based cohort study in men. J Clin Oncol 2008, 26:5576-5582.
47. Sorrentino P., D'Angelo S., Ferbo U., Micheli P., Bracigliano A., Vecchione R. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis. J Hepatol 2009, 50:351-357.
48. Siegel A.B., Zhu A.X. Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer 2009, 115:5651-5661.
49. Starley B.Q., Calcagno C.J., Harrison S.A. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 2010, 51:1820-1832.
50. Blonski W., Kotlyar D.S., Forde K.A. Non-viral causes of hepatocellular carcinoma. World J Gastroenterol 2010, 16:3603-3615.